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ABSTRACT
Hypergonadotropic hypogonadism is characterized by decreased 
gonadal function due to the inability of the gonads to respond to 
pituitary gonadotropins. Hypergonadotropic hypogonadism in fe­
males has many causes, among which are ovarian dysgenesis and 
abnormalities of the ovarian receptors for the pituitary gonadotro­
pins. We evaluated a woman who presented with amenorrhea due to 
hypergonadotropic hypogonadism, but who had structurally normal 
ovaries* She is a sister of two previously identified 46fXY male 
pseudohermaphrodites with Ley dig cell hypoplasia. Injection of hCG 
did not cause any change in plasma levels of estradiol or progesterone, 
suggesting complete ovarian resistance to LH. Analysis of the DNA 
sequence of the LH receptor gene revealed that the patient is ho­
mozygous for the same single base change as her two brothers. This 
mutation causes substitution of an alanine residue by a proline at
position 593. In vitro analysis of the mutant LH receptor in cultured 
human embryonic kidney 293 cells documented that the receptor is 
unable to stimulate adenylyl cyclase in response to hCG. Plasma 
levels of estradiol and progesterone were low, whereas LH and FSH 
levels were increased. On histological analysis of the ovary, follicles 
were seen at all developmental stages. Nonetheless, primary amen­
orrhea had been present for 5 yr, and repeated measurements of 
plasma estradiol and progesterone indicate that ovulation does not 
occur. These results document the existence of inherited LH resis­
tance as a cause of primary amenorrhea in women. The combined 
clinical and molecular observations are consistent with previous ex­
perimental data suggesting that in humans, LH is necessary for 
ovulation but follicular maturation can occur in the presence of FSH 
alone. (J Clin Endocrinol Metab 81: 3850-3854, 1996)
T HE PITUITARY hormones FSH and LH have an es­
sential role in the regulation of gonadal function (1 ,
2). In the cycling ovary, the growth of small follicles is 
dependent on FSH. Some small antral follicles develop 
into preovulatory (or Graafian) follicles. Ovulation is sub­
sequently induced by a peak in the level of circulating LH. 
The pituitary secretion of LH and FSH is negatively con­
trolled by the gonadal hormones estradiol and progester­
one. In hypergonadotropic hypogonadal patients, the 
ovary does not respond to LH or FSH with the secretion 
of steroid hormones, and the absence of the negative feed­
back results in elevated levels of these gonadotropins (3). 
In this report we describe a patient with amenorrhea and 
infertility due to hypergonadotropic hypogonadism. She 
is a sister of two 46,XY male pseudohermaphrodites in a 
pedigree (Fig. 1) that was previously analyzed by us (4). 
The two male pseudohermaphrodites have Leydig cell 
hypoplasia due to a homozygous inactivating mutation in 
the LH receptor gene. This suggested that the primary 
amenorrhea and infertility in the present patient might
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also be caused by this mutation. Indeed, plasma levels of 
estradiol and progesterone were low, suggesting the ab­
sence or hypofunction of ovarian follicles with regard to 
LH-dependent hormone production. Histological exami­
nation of ovarian tissues revealed complete follicular de­
velopment, suggesting uncompromised response to FSH, 
The subject was, therefore, evaluated for an inherited de­
fect of the ovarian receptor for LH. DNA analysis revealed 
a homozygous nucleotide change in the LH receptor gene, 
rendering the LH receptor molecule unable to stimulate 
cAMP production upon stimulation with hCG. We con­
clude that inherited complete ovarian resistance to LH 
causes anovulation in the presence of normal follicular 
maturation.
Subjects and Methods
The patient
A 21-yr-old w om an  w as referred for evaluation of amenorrhea and 
infertility. She is 1  of 15 siblings b o m  to consanguineous parents (Fig. 
1). Normal menses never occurred. From the age of 16 yr, irregular 
spotting occurred on the average every 6 months. Gynecological exam­
ination revealed a norm al-sized vagina with thin walls and no secretory 
function. Bone mass m easured  b y  bone densitometry was significantly 
reduced. The patient w as otherwise healthy and had normal develop­
ment, with full m aturation  of prim ary and secondary characteristics.
Pelvic u ltrasonography revealed an enlarged right ovary (22 cm3) 
with a large cyst. The left ovary w as of normal size (5 cm3). The uterus 
w as small, b u t of norm al shape. Uterine volume was determined by 
ultrasonography to be 20 cm5 (normal uterine volume at menarche, 
25-90 cm ).
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Hormonal evaluation
Progesterone, estradiol, and cortisol w ere m easured by an immun- 
ofluorometric assay. 17-Hydroxyprogesterone, androstenedione, dehy- 
droepiandrosterone (DHEA), DHEA sulfate, and  testosterone were de­
termined using RIAs, LH and FSH were determined using an 
immunochemiluminescence assay (Delphia, Wallac, Finland). Normal 
hormone levels are indicated in the table. GnRH-induced increases in 
plasma LH and FSH were determined 1 h  after an iv injection of 100 /xg 
GnRH (Ayerst Laboratories, Rouse P o in t  IL). For the ACTH challenge 
test, plasma hormone levels were m easured 1 h  after the injection of 250 
jLig Cosyntropin (Organon, Oss, The Netherlands). The hCG sensitivity 
of steroid hormone production was evaluated 48 h after a single injection 
of 6000 IU Pregnyl (Organon).
Ovarian histology
An ovarian biopsy was obtained during  video laparoscopy. Tissue 
was fixed in buffered 4% /;-form aldehyde, paraffin-embedded, sec­
tioned, and stained with hemoxylin-eosin. All procedures were carried 
out in the course of normal patient care after appropriate informed 
consent had been obtained.
DNA analysis and receptor expression
DNA fragments were amplified w ith  PCR from genomic DNA iso­
lated from peripheral blood (5) using prim ers previously described (4).
F ig . 1 . Pedigree of family. The pedigree of this family reveals con­
sanguinity of the parents of the patient, The patient’s two 46,XY 
siblings with Ley dig cell hypoplasia are also indicated (square with a 
dot),
TABLE 1. Hormone levels
Amplified DNA fragments were isolated after agarose gel electrophore­
sis and sequenced using the cycle sequencing kit from BRL (Life Tech­
nologies, G rand Island, NY). H um an embryonic kidney 293 cells w ere 
transfected w ith LH receptor expression constructs (6) and, after 48 h, 
treated for 2 h with hCG, Binding of [125I]hCG and cAMP production  
were m easured  as described previously (4).
Results
Evaluation o f the pituitary’•gonadal axis indicates LH  
resistance
Determination of plasma hormones revealed low normal 
to normal levels of estradiol, progesterone, 17-hydroxypro­
gesterone, DHEA, androstenedione, and testosterone (Table 
1). Estradiol and progesterone levels were 240 pm ol/L  
(range, 84-447; n — 6) and 2.0 nmol/L (range, 0.6-3.8; n  =
3), respectively, To exclude deficiencies in the steroidogenic 
enzymes, an ACTH challenge test was performed. Cortisol 
and the adrenal androgens showed a normal response (Table 
1). In contrast, hCG injection did not induce any response in 
the plasma levels of the steroid hormones measured (Table 
1), leading to the diagnosis of LH resistance. Plasma levels of 
LH and FSH were elevated and responded normally to a 
GnRH challenge (Table 1 ). Serum inhibin and PRL levels 
were within the normal range.
Ovarian histology
Histological analysis of an ovarian biopsy showed all 
stages of follicular development, including primordial folli­
cles, preantral follicles with oocytes and a few granulosa cell 
layers, and follicles with a large antrum and well developed 
thecal cell layer. In these antral follicles, the thecal cells had 
a luteinized appearance, whereas the granulosa cells in the 
same follicle did not show any signs of luteinization (Fig. 2A). 
Other areas of the ovarian biopsy contained multiple pri­
mordial follicles (Fig. 2B). No preovulatory follicles, corpora 
lute a, or corpora albicans were present.
Mutation in the LH receptor gene
DNA sequence analysis of the sixth transmembrane seg­
ment and flanking regions of the LH receptor gene was 
performed, which indicated a homozygous single nucleotide 
change of guanine to cytidine at position 1787 of the gene 
(Fig. 3). This mutation is identical to that previously identi­
fied in the patient's two 46,XY brothers with Ley dig cell 
hypoplasia (4) and causes substitution of a proline residue 
for alanine 593 at the border of the sixth transmembrane 
segment and the third extracellular loop of the receptor mol­
Basal hCG ACTH GnRH
LH (IU/L) 10 (0.95-8.4) 35 (7.6-31.7)
FSH (IU/L) 8.7 (1.7-5.9) 11 (4,6-11.7)
Progesterone (nmol/L) 2,0 (1.2-7.0) 0.64
Estradiol (pmol/L 270 (130-500) 110
17-hydroxyprogesterone (nmol/L) 2.4 (0.7-3.3) 1.51 6.35(4.3 ±1.8)
DHEA (nmol/L) 22.9 (6.2-20.1) 12.13 34,7 (27.4± 15) •
DHEA sulfate (nmol/L) 1587 (1104-8956) 3031
Androstenedione (nmol/L) 3.49 (2.0-6.6) 3.84 10.13
Cortisol (nmol/L) 193.13 (193-855) 634
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F ig . 2. Histology of ovarian biopsy. A, 
A partially collapsed antral follicle with 
granulosa cells (short arrow) and thecal 
cells (long arrow). The thecal cells have 
a luteinized appearance. The adjacent 
granulosa cells do not show luteal dif­
ferentiation. B, A group of primordial 
follicles. Areas containing primordial 
follicles with a normal appearance were 
found near the ovarian cortex (hemoxy­
lin-eosin staining; magnification, X400).
ecule, The father of these patients carried both the mutated 
and wild-type alleles of the LH receptor gene (Fig. 3).
In in vitro transfection experiments, the effect of this mu­
tation on LH receptor function was determined. 293 cells 
transfected with the wild-type LH receptor expression con­
struct responded to hCG treatment with a more than 300-fold 
increase in cAMP production (Fig, 4). In contrast, cells trans­
fected with the mutant LH receptor expression plasmid did 
not respond (Fig. 4), Ligand binding to cells transfected with 
mutant receptors was reduced. To investigate whether this 
low binding is the cause of the inability of these receptors to 
couple to the intracellular Gs protein, 293 cells were trans­
fected with decreasing amounts of wild-type LH receptor 
expression plasmid (Fig. 4). At 0.1 jxg DNA, a robust hCG- 
induced cAMP response was found, although the cells 
showed hCG binding similar to that of cells transfected with
10 /xg mutant LH receptor expression plasmid (Fig. 4).
Discussion
Hypergonadotropic hypogonadism is caused by the ab­
sence of the normal gonadal response to the pituitary hor­
mones LH and FSH (1). This syndrome has many causes, 
among which chromosomal abnormalities such as Turner's 
syndrome are frequent (1, 3). However, in subjects with a 
normal karyotype, gonadotropin receptor defects could ex­
plain the reduced gonadal activity. Recently, an inactivating 
FSH receptor gene mutation was described in families with 
a hereditary form of ovarian dysgenesis (7, 8). In these 
women, the inability of the ovaries to respond to FSH re­
sulted in the absence of follicle growth, low gonadal hor­
mone production, and variably developed secondary sex 
characteristics in the presence of high levels of FSH and LH.
The patient described in this report presented with pri­
mary amenorrhea and infertility. The presence of two 46,XY
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siblings with hypoplasia of Ley dig cells in her pedigree 
prompted us to screen for LH receptor mutations. Indeed, 
homozygosity for the same mutation was found in both the
two
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P ig . 3. LH receptor mutation in a woman with hypergonadotropic 
hypogonadism. The DNA sequence surrounding nucleotide 1787 of 
the LH receptor gene is shown for the patient, her father, and a 
normal control. Note the homozygous conversion of G1787 to C in the 
patient. The father is heterozygous for this mutation and carries both 
the G1787 and C1787 alleles.
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Fig. 4. Mutant LH receptor does not 
couple to cAMP production. hCG bind- 
ing and hCG-stimulated cAMP produc­
tion were determined after in vitro ex­
pression of wild-type and mutant 
(Ala693Pro) LH receptors in 293 cells. 
Top ,  [126I]hCG binding to transfected 
293 cells. Binding is expressed as 
counts per min of [125I]hCG/well. Bot- 
tom , hCG-stimulated cAMP production 
in control conditions (open bars) and 
with 10 ng/mL (hatched bars) and 1 
jug/mL (closed bars) hCG. cAMP levels 
are normalized to luciferase activities 
measured in the same cells that were 
cotransfected with a pRSV-luciferase 
expression plasmid to control for trans­
fection efficiency. LHR-mut, The LH re­
ceptor carrying the Ala593 to Pro muta­
tion. Maximal cAMP levels found in 
cells transfected with the mutant LH 
receptor were lower than 0.08 pmol/rel- 
ative light units.
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with Leydig cell hypoplasia. Expression of the mutant LH 
receptor revealed that the receptor was unable to couple the 
hCG signal to cAMP production. Furthermore, this receptor 
is poorly expressed at the plasma membrane, as indicated by 
the low hCG binding, but this low expression is not the cause 
of the absence of coupling. The Ala593 to Pro change in the 
sixth transmembrane segment probably confers aberrant 
folding of the receptor molecule during its synthesis and 
modification in the endoplasmic reticulum and Golgi appa­
ratus. This may result in faulty trafficking and subsequent 
low expression at the plasma membrane.
The ovarian LH resistance in this case is associated with 
normal development of female internal and external geni­
talia and infertility. Follicular development also occurs nor­
mally, at least up to the antral stage. However, ovulation 
does not occur, as borne out by the history of amenorrhea and 
the absence of signs of ovulation in the biopsy sample, The 
small size of the uterus as well as the presence of a thin walled 
hypo secretory vagina in a subject with reduced bone mass 
suggest that this patient has had a long standing hypoestro-
1 0.1 0.01
LHR wt
10
pg DNA transfected
/
//
LHR-mut
control
y//A  10 ng hCG
1 pg hCG
1 0.1 0.01 10
LHR wt I pg DNA transfected
3854 TOLEDO E T AL JCE & M • 1996Vol 81 • No 11
genization. Neither estradiol nor progesterone, measured at 
six different time points, reached levels found during the 
ovulatory or luteal phase of the cycle in normal women. 
Because the FSH signal is unimpaired, conversion of andro­
gens by FSH-induced aromatase activity in the growing fol­
licles may explain the residual estradiol in plasma, which 
was in the borderline to low normal range for the follicular 
stage of the cycle. Whether these androgens originate from 
the adrenal or represent basal ovarian production cannot be 
determined, and a dexamethasone suppression test was not 
performed.
The presence of estradiol explains the relatively minor 
increase in plasma gonadotropin hormone concentrations 
compared to the very high LH and FSH levels found in 
ovarian dysgenesis caused by the FSH receptor mutation (8), 
The absence of follicular stimulation in these FSH receptor- 
deficient patients results in much lower estradiol production. 
The lack of FSH-induced inhibin removes the negative feed­
back effect on gonadotropin levels (3, 8).
Amenorrhea has previously been noted in female siblings 
of 46,XY male hermaphrodites with Leydig cell hypoplasia 
(9). The present results indicate that such patients have in­
herited unresponsiveness to LH as the basis for their amen­
orrhea. After submission of this manuscript, a woman was 
described with an inactivating mutation of the LH receptor 
gene that leads to a truncation of the LH receptor protein (10). 
The data in this report confirm the hormonal and LH receptor 
expression experiments described here (10). The fact that 
male pseudohermaphroditism and female amenorrhea are 
caused by the same genetic defect allows a tentative estimate 
of the frequency of inherited resistance to LH in females. At 
least 20 cases of Leydig cell hypoplasia have been reported 
in the literature, and many more have probably been erro­
neously diagnosed as androgen sensitivity (testicular femi­
nization). Therefore, inherited resistance to LH should be 
considered in all amenorrheic females who fail to respond to 
hCG injection with an increase in steroid hormone levels.
Hypogonadism also occurs in cases with disrupted LH or 
FSH /3-subunit genes. An inherited form of LH )3-subunit 
inactivity was found in a man with hypogonadism (11). As 
none of the female siblings was homozygous for this muta­
tion, the effect of genetic absence of LH on female function 
is unknown. Other genetic variant forms of LH have been 
reported, but these were without any obvious clinical effect 
(12). Primary amenorrhea and infertility associated with very 
low plasma estrogen levels and poorly developed secondary 
sex characteristics were observed in a patient with absence
of FSH due to a mutation in the FSH )3-subunit gene (13). The 
endocrine observations in this case are comparable to the 
findings in ovarian dysgenesis (8), underscoring the idea that 
defects in the FSH pathway of ovarian stimulation have more 
severe clinical consequences than do changes in the LH re­
ceptor signal transduction pathway.
In conclusion, we show that complete ovarian resistance to 
LH due to a homozygous inactivating mutation in the LH 
receptor gene, results in amenorrhea and anovulation in the 
presence of normal female sex differentiation and follicular 
development. In humans, LH is necessary for ovulation, but 
normal follicular maturation is possible in the presence of 
FSH alone.
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